BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18663357)

  • 1. E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity.
    Danielian PS; Friesenhahn LB; Faust AM; West JC; Caron AM; Bronson RT; Lees JA
    Oncogene; 2008 Nov; 27(51):6561-70. PubMed ID: 18663357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2f3a and E2f3b contribute to the control of cell proliferation and mouse development.
    Chong JL; Tsai SY; Sharma N; Opavsky R; Price R; Wu L; Fernandez SA; Leone G
    Mol Cell Biol; 2009 Jan; 29(2):414-24. PubMed ID: 19015245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
    Aslanian A; Iaquinta PJ; Verona R; Lees JA
    Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2f3b plays an essential role in myogenic differentiation through isoform-specific gene regulation.
    Asp P; Acosta-Alvear D; Tsikitis M; van Oevelen C; Dynlacht BD
    Genes Dev; 2009 Jan; 23(1):37-53. PubMed ID: 19136625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse development with a single E2F activator.
    Tsai SY; Opavsky R; Sharma N; Wu L; Naidu S; Nolan E; Feria-Arias E; Timmers C; Opavska J; de Bruin A; Chong JL; Trikha P; Fernandez SA; Stromberg P; Rosol TJ; Leone G
    Nature; 2008 Aug; 454(7208):1137-41. PubMed ID: 18594513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor compensation during mammary gland development in E2F knockout mice.
    To B; Andrechek ER
    PLoS One; 2018; 13(4):e0194937. PubMed ID: 29617434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription Factor E2F3a in Nucleus Accumbens Affects Cocaine Action via Transcription and Alternative Splicing.
    Cates HM; Heller EA; Lardner CK; Purushothaman I; Peña CJ; Walker DM; Cahill ME; Neve RL; Shen L; Bagot RC; Nestler EJ
    Biol Psychiatry; 2018 Aug; 84(3):167-179. PubMed ID: 29397901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rb-mediated neuronal differentiation through cell-cycle-independent regulation of E2f3a.
    Chen D; Opavsky R; Pacal M; Tanimoto N; Wenzel P; Seeliger MW; Leone G; Bremner R
    PLoS Biol; 2007 Jul; 5(7):e179. PubMed ID: 17608565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F3b over-expression in ovarian carcinomas and in BRCA1 haploinsufficient fallopian tube epithelium.
    Smith NL; Welcsh P; Press JZ; Agnew KJ; Garcia R; Swisher EM
    Genes Chromosomes Cancer; 2012 Nov; 51(11):1054-62. PubMed ID: 22887716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma.
    Kent LN; Bae S; Tsai SY; Tang X; Srivastava A; Koivisto C; Martin CK; Ridolfi E; Miller GC; Zorko SM; Plevris E; Hadjiyannis Y; Perez M; Nolan E; Kladney R; Westendorp B; de Bruin A; Fernandez S; Rosol TJ; Pohar KS; Pipas JM; Leone G
    J Clin Invest; 2017 Mar; 127(3):830-842. PubMed ID: 28134624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of E2F3b in human HepG2 liver cancer cell line.
    Lu Y; Li W
    J Cell Biochem; 2018 Apr; 119(4):3429-3439. PubMed ID: 29135049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex transcriptional regulatory mechanisms control expression of the E2F3 locus.
    Adams MR; Sears R; Nuckolls F; Leone G; Nevins JR
    Mol Cell Biol; 2000 May; 20(10):3633-9. PubMed ID: 10779353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model.
    Paulson QX; McArthur MJ; Johnson DG
    Cell Cycle; 2006 Jan; 5(2):184-90. PubMed ID: 16340309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing regulation of Sox2 by cell-cycle effectors E2f3a and E2f3b in neural stem cells.
    Julian LM; Vandenbosch R; Pakenham CA; Andrusiak MG; Nguyen AP; McClellan KA; Svoboda DS; Lagace DC; Park DS; Leone G; Blais A; Slack RS
    Cell Stem Cell; 2013 Apr; 12(4):440-52. PubMed ID: 23499385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo.
    Cloud JE; Rogers C; Reza TL; Ziebold U; Stone JR; Picard MH; Caron AM; Bronson RT; Lees JA
    Mol Cell Biol; 2002 Apr; 22(8):2663-72. PubMed ID: 11909960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of E2F5/p130, but not E2F5 alone, can inhibit E2F-induced cell cycle entry in transgenic mice.
    Chen Q; Liang D; Overbeek PA
    Mol Vis; 2008 Mar; 14():602-14. PubMed ID: 18385796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role for E2F3b in regulating cocaine action in the prefrontal cortex.
    Cates HM; Bagot RC; Heller EA; Purushothaman I; Lardner CK; Walker DM; Peña CJ; Neve RL; Shen L; Nestler EJ
    Neuropsychopharmacology; 2019 Mar; 44(4):776-784. PubMed ID: 30552390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.
    Hurst CD; Tomlinson DC; Williams SV; Platt FM; Knowles MA
    Oncogene; 2008 Apr; 27(19):2716-27. PubMed ID: 18037967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop.
    Timmers C; Sharma N; Opavsky R; Maiti B; Wu L; Wu J; Orringer D; Trikha P; Saavedra HI; Leone G
    Mol Cell Biol; 2007 Jan; 27(1):65-78. PubMed ID: 17167174
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Cates HM; Lardner CK; Bagot RC; Neve RL; Nestler EJ
    eNeuro; 2019; 6(2):. PubMed ID: 30963104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.